Form 144 | Janux Therapeutics(JANX.US) 10% Stockholder Proposes to Sell 12.75 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 23, $Janux Therapeutics(JANX.US)$ 10% Stockholder Avalon BioVentures SPV I, L.P. intends to sell 248.8K shares of its common stock on Oct 23, with a total market value of
US stocks anomaly | Janux Therapeutics rose 4% before the market, with directors acquiring over 50 million US dollars in shareholding.
On October 23, Gelunhui | Janux Therapeutics (JANX.US) rose 4% before the market opened to $54.9. According to the documents disclosed by the Securities and Exchange Commission (SEC) on October 22, Director RA CAPITAL MANAGEMENT, L.P. of Janux Therapeutics increased its shareholding by 1.2 million shares of common stock at an average price of $44.75 per share on October 18, with a value of approximately $53.7 million. (Gelonghui)
Janux Therapeutics(JANX.US) 10% Shareholder Buys US$53.7 Million in Common Stock
$Janux Therapeutics(JANX.US)$ 10% Shareholder RA CAPITAL MANAGEMENT, L.P. purchased 1.2 million shares of common stock on Oct 18, 2024 at an average price of $44.75 for a total value of $53.7 million.
Form 144 | Janux Therapeutics(JANX.US) 10% Stockholder Proposes to Sell 6.08 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 18, $Janux Therapeutics(JANX.US)$ 10% Stockholder Avalon BioVentures SPV I, L.P. intends to sell 120.68K shares of its common stock on Oct 18, with a total market value
Form 144 | Janux Therapeutics(JANX.US) 10% Stockholder Proposes to Sell 4.57 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 16, $Janux Therapeutics(JANX.US)$ 10% Stockholder Avalon BioVentures SPV I, L.P. intends to sell 91,539 shares of its common stock on Oct 16, with a total market value of
Companies Like Janux Therapeutics (NASDAQ:JANX) Can Afford To Invest In Growth